AI-generated summary
The authors pooled 28 randomised controlled trials of repeated low-level red-light therapy in children with myopia. They report duration-dependent slowing of myopia progression up to one year, with larger effects in children with higher baseline myopia, and mild, transient adverse events. The authors note that longer-term trials with comprehensive retinal safety assessment are still needed.
- Participants
- 3,573
- Studies included
- 28
- Who or what was studied
- Children under 18 years with myopia
- Limits stated in the abstract
- The authors state that evidence for axial length is of lower certainty and that longer-term trials with comprehensive retinal safety assessment are required.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Myopia, Repeated low-level red light, Systematic review, Meta-analysis, Randomized controlled trial, Trial registration, Primary outcome, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.